Business

Appointment of CFO

Appointment of CFO.

articleEkf Diagnostics Holdings PlcSeptember 12, 20235/company/ekf-diagnostics-holdings-plc/news/appointment-of-cfo-37
Appointment of CFO

About this update from Ekf Diagnostics Holdings Plc

[{"type":"text","content":"\n\nEKF Diagnostics Holdings plc\n(\"EKF\", the \"Company\" or the \"Group\")\n \nAppointment of CFO\n \nEKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostic business, announces the appointment of Stephen (\"Steve\") Young as Chief Financial Officer (\"CFO\") and to the EKF Board, effective immediately. Steve Young has been working as a consultant at EKF for the last two months alongside the Group's outgoing CFO to affect an orderly handover.\n \nSteve is an experienced Finance Director and CFO and joins the Company from Trellus Health plc (\"Trellus\") where he has served as Interim Chief Financial Officer, in a non-board capacity, since August 2022.\n \nPrior to working with Trellus, Steve served as CFO and Company Secretary (a non-Director role) with Axiom Manufacturing Limited, a contract electronic manufacturer. Having joined in 2009 when Axiom generated close to £12m in revenue and was loss making, he supported the restructuring of the business to over £62m turnover in 2020. Axiom also acquired Greeve Limited in 2016 where Steve became a Director.\n \nIn addition to this, Steve has experience with AIM-quoted businesses having served as CFO at Pure Wafer plc and, before this, BBI Holdings plc (\"BBI\") which admitted to AIM in 2004. During Steve's seven-year tenure at BBI he reported to EKF Executive Chair Julian Baines when he was CEO of BBI. Steve is a member of the Chartered Institute of Management Accountants (CIMA).\n \nJulian Baines, Executive Chair of EKF, commented: \"I'm pleased to welcome Steve Young to the EKF team and to work again with him after doing so at BBI Holdings plc. Steve is a highly dependable and experienced CFO, with a strong working knowledge of how AIM companies operate, so I look forward to his support as we continue to execute against our plans for significant long-term growth.\"\n \nAdditional Disclosures Required under the AIM Rules for Companies\nStephen Michael Young (aged 60) has held the following directorship or partnerships in the past five years:\n \nCurrent directorships and partnerships:\n·    N/A\n \nPrevious directorships and partnerships held in the past five years:\n·    Greeve Limited\n \nStephen currently holds 85,000 ordinary shares in the Company.\n \nSave as disclose...

More updates from Ekf Diagnostics Holdings Plc